# SOX as Salvage Treatment in Nasopharyngeal Carcinoma

> **NCT01403259** · PHASE2 · TERMINATED · sponsor: **Fudan University** · enrollment: 16 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** S-1 plus oxaliplatin

## Key facts

- **NCT ID:** NCT01403259
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** poor accrual of eligible patients
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01403259

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01403259, "SOX as Salvage Treatment in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01403259. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*